Who We are

Trialcelerate AI is an AI-native company focused on accelerating the development of life-saving medicines leveraging data, technology and AI.

Our premier product Trialcelerate Olive™ is an AI-powered clinical development intelligence platform built to eliminate the delays and inefficiencies that slow high value therapies from reaching patients.

We unify protocol-informed data assessment, feasibility intelligence, and RWE generation into one seamless workflow, turning fragmented data and manual processes into rapid, fit-for-purpose insights.

Our Mission

At Trialcelerate AI, we exist to bridge the gap between scientific innovation and patient impact by combining deep life sciences expertise with AI-powered intelligence to accelerate evidence generation, clinical development, and access to life-saving therapies.

Our values

Accelerating Patient Impact

We believe patients should not have to wait for life-changing therapies. Everything we do is focused on helping life sciences organizations accelerate the development, delivery, and accessibility of innovative medicines.

Science-Driven Excellence

Our solutions are grounded in deep expertise across clinical development, real-world evidence, healthcare data, and life sciences, ensuring every insight is rigorous, reliable, and actionable.

Efficiency Without Compromise

We are committed to reducing the time, cost, and operational burden of clinical development while maintaining the highest standards of scientific and analytical integrity.

Transforming What's Possible

We believe the convergence of science, data, and AI represents a historic opportunity to reimagine how therapies are developed. Our mission is to help organizations make better decisions faster, bringing new treatments to patients sooner and improving outcomes at scale.